Literature DB >> 21156436

Neuropsychological functioning in PLS: a comparison with ALS.

Gloria M Grace1, J B Orange, Ann Rowe, Karen Findlater, Morris Freedman, Michael J Strong.   

Abstract

OBJECTIVE: In order to characterize the nature and extent of neuropsychological dysfunction in primary lateral sclerosis (PLS), we studied prospectively cognitive, emotional, and behavioral functioning in PLS, and compared performances to functioning in amyotrophic lateral sclerosis (ALS).
METHODS: Eighteen patients with PLS and 13 patients with ALS completed a neuropsychological test battery assessing both cognitive skills and emotional/behavioral functioning.
RESULTS: Both PLS and ALS groups scored broadly within normal limits (mean T-scores greater than 40) on all cognitive measures and no significant between-group differences were found with the exception of one variable. However, when examined on a case by case basis, the data revealed considerable heterogeneity amongst patients in both groups. Overall, 39% of PLS patients and 31% of ALS patients were considered cognitively impaired. Ahigher than expected frequency of abnormal scores was noted for several tests of executive function in both groups, and a majority of PLS patients also exhibited abnormal behavioural symptoms. There was no relationship in PLS or ALS groups between cognitive functioning and disease duration, current site of disease, site of onset, functional status, and respiratory variables. Comparison between the PLS and ALS groups indicated virtually no differences in cognitive test scores and overall emotional/behavioural symptoms.
CONCLUSIONS: We observed deficits in cognition and behaviour in a significant proportion of PLS patients which were comparable to those observed in ALS cases. Although deficits were not in the range of frontotemporal dementia, both ALS and PLS cases demonstrated deficits most prominently on tests of executive functioning.

Entities:  

Mesh:

Year:  2011        PMID: 21156436

Source DB:  PubMed          Journal:  Can J Neurol Sci        ISSN: 0317-1671            Impact factor:   2.104


  13 in total

Review 1.  The frontotemporal syndromes of ALS. Clinicopathological correlates.

Authors:  Michael Joseph Strong; Wencheng Yang
Journal:  J Mol Neurosci       Date:  2011-08-02       Impact factor: 3.444

2.  Deciphering amyotrophic lateral sclerosis: what phenotype, neuropathology and genetics are telling us about pathogenesis.

Authors:  John Ravits; Stanley Appel; Robert H Baloh; Richard Barohn; Benjamin Rix Brooks; Lauren Elman; Mary Kay Floeter; Christopher Henderson; Catherine Lomen-Hoerth; Jeffrey D Macklis; Leo McCluskey; Hiroshi Mitsumoto; Serge Przedborski; Jeffrey Rothstein; John Q Trojanowski; Leonard H van den Berg; Steven Ringel
Journal:  Amyotroph Lateral Scler Frontotemporal Degener       Date:  2013-05       Impact factor: 4.092

3.  Self-Regulation and Executive Functioning as Related to Survival in Motor Neuron Disease: Preliminary Findings.

Authors:  Natasha E Garcia-Willingham; Abbey R Roach; Edward J Kasarskis; Suzanne C Segerstrom
Journal:  Psychosom Med       Date:  2018-09       Impact factor: 4.312

4.  Primary lateral sclerosis and the amyotrophic lateral sclerosis-frontotemporal dementia spectrum.

Authors:  Smriti Agarwal; Elizabeth Highton-Williamson; Jashelle Caga; José M Matamala; Thanuja Dharmadasa; James Howells; Margaret C Zoing; Kazumoto Shibuya; Nimeshan Geevasinga; Steve Vucic; John R Hodges; Rebekah M Ahmed; Matthew C Kiernan
Journal:  J Neurol       Date:  2018-06-04       Impact factor: 4.849

Review 5.  Controversies and priorities in amyotrophic lateral sclerosis.

Authors:  Martin R Turner; Orla Hardiman; Michael Benatar; Benjamin R Brooks; Adriano Chio; Mamede de Carvalho; Paul G Ince; Cindy Lin; Robert G Miller; Hiroshi Mitsumoto; Garth Nicholson; John Ravits; Pamela J Shaw; Michael Swash; Kevin Talbot; Bryan J Traynor; Leonard H Van den Berg; Jan H Veldink; Steve Vucic; Matthew C Kiernan
Journal:  Lancet Neurol       Date:  2013-03       Impact factor: 44.182

6.  The Relationship between Depressive Symptoms, Disease State, and Cognition in Amyotrophic Lateral Sclerosis.

Authors:  Laura Jelsone-Swain; Carol Persad; Kristen L Votruba; Sara L Weisenbach; Timothy Johnson; Kirsten L Gruis; Robert C Welsh
Journal:  Front Psychol       Date:  2012-12-17

7.  Action processing and mirror neuron function in patients with amyotrophic lateral sclerosis: an fMRI study.

Authors:  Laura Jelsone-Swain; Carol Persad; David Burkard; Robert C Welsh
Journal:  PLoS One       Date:  2015-04-17       Impact factor: 3.240

8.  Imaging findings associated with cognitive performance in primary lateral sclerosis and amyotrophic lateral sclerosis.

Authors:  Avner Meoded; Justin Y Kwan; Tracy L Peters; Edward D Huey; Laura E Danielian; Edythe Wiggs; Arthur Morrissette; Tianxia Wu; James W Russell; Elham Bayat; Jordan Grafman; Mary Kay Floeter
Journal:  Dement Geriatr Cogn Dis Extra       Date:  2013-08-16

9.  Structural imaging differences and longitudinal changes in primary lateral sclerosis and amyotrophic lateral sclerosis.

Authors:  Justin Y Kwan; Avner Meoded; Laura E Danielian; Tianxia Wu; Mary Kay Floeter
Journal:  Neuroimage Clin       Date:  2012-12-24       Impact factor: 4.881

10.  Eye-tracking in amyotrophic lateral sclerosis: A longitudinal study of saccadic and cognitive tasks.

Authors:  Malcolm Proudfoot; Ricarda A L Menke; Rakesh Sharma; Claire M Berna; Stephen L Hicks; Christopher Kennard; Kevin Talbot; Martin R Turner
Journal:  Amyotroph Lateral Scler Frontotemporal Degener       Date:  2015-08-27       Impact factor: 4.092

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.